Research & Development (Pharma & Healthcare)

Pharma & Healthcare R&D Reports

Research & Development (Pharma & Healthcare) Market Research Reports, Industry Analysis and Trends

 

Publication Single User License (PDF) Price
Exenatide  - Comprehensive patent search

Exenatide - Comprehensive patent search

Date Published: Sep 16 2014

Exenatide - Comprehensive patent search Treatment of type 2 diabetes mellitus optionally in combination with Metformin and/or, a sulfonylurea or a thiazolidinedione; or as adjunctive therapy to basal insulin optionally in combination with Metformin and/or Pioglitazone; in adults who have not achieved adequate glycaemic control Amylin (Byetta, Bydureon); Bristol-Myers Squibb (Byetta, Bydureon)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$9,300.00
Eculizumab  - Comprehensive patent search

Eculizumab - Comprehensive patent search

Date Published: Sep 16 2014

Eculizumab - Comprehensive patent search Treatment of paroxysmal nocturnal haemoglobinuria, optionally in combination with a meningococcal vaccine; treatment of atypical haemolytic uraemic syndrome, optionally in combination with a meningococcal vaccine Alexion (Soliris)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$9,300.00
Abatacept  - Comprehensive patent search

Abatacept - Comprehensive patent search

Date Published: Sep 16 2014

Abatacept - Comprehensive patent search Treatment of adult rheumatoid arthritis, optionally in combination with DMARDs optionally other than TNF antagonists; Treatment of juvenile idiopathic arthritis, optionally in combination with Methotrexate; Treatment of juvenile rheumatoid arthritis Bristol Myers Squibb (Orencia)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$9,300.00
Aflibercept  - Comprehensive patent search

Aflibercept - Comprehensive patent search

Date Published: Sep 16 2014

Aflibercept - Comprehensive patent search Treatment of neovascular wet age-related macular degeneration; Treatment of macular edema following central retinal vein occlusion; Treatment of metastatic colorectal cancer that is resistant to or has progressed following an Oxaliplatin-containing regimen in combination with 5-Fluorouracil, Leucovorin and Irinotecan Regeneron (Eylea); Sanofi (Zaltrap, Lidaveg, Aflitiv); Bayer (Eylea)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$9,300.00
Denosumab  - Comprehensive patent search

Denosumab - Comprehensive patent search

Date Published: Sep 16 2014

Denosumab - Comprehensive patent search Treatment to increase bone mass in men with osteoporosis at high risk for fracture; prevention of skeletal related events in patients with bone metastases from solid tumours; treatment of giant cell tumour of bone or skeletally mature adolescents that is recurrent, or unresectable, or resectable but associated with severe morbidity; reduction of the risk of vertebral, non-vertebral and hip fractures; treatment of postmenopausal women with osteoporosis at high risk for fracture; treatment to increase bone mass in men with nonmetastatic prostate cancer

$9,300.00
R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

Date Published: Sep 15 2013
$7,941.00
Ledipasvir  - Comprehensive patent search

Ledipasvir - Comprehensive patent search

Date Published: Sep 16 2014

Ledipasvir - Comprehensive patent search Treatment of chronic HCV infection in combination with Sofosbuvir Gilead

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Aprepitant  - Comprehensive patent search

Aprepitant - Comprehensive patent search

Date Published: Sep 16 2014

Aprepitant - Comprehensive patent search Prevention of chemotherapy induced nausea and vomiting (CINV) in combination with Dexamethasone and other antiemetic agents including 5-HT3 antagonist; Prevention of postoperative nausea and vomiting (PONV) Merck (Emend)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Fosaprepitant  - Comprehensive patent search

Fosaprepitant - Comprehensive patent search

Date Published: Sep 16 2014

Fosaprepitant - Comprehensive patent search Prevention of chemotherapy induced nausea and vomiting (CINV) in combination with Dexamethasone and/or other antiemetic agents, preferably 5-HT3 antagonist Merck (Emend, Ivemend, Emend IV)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Paliperidone  - Comprehensive patent search

Paliperidone - Comprehensive patent search

Date Published: Sep 16 2014

Paliperidone - Comprehensive patent search Treatment of schizophrenia, optionally in combination with antidepressants and/or mood stabilisers, preferably lithium or Valproate Janssen (Invega, Invega Sustenna); Johnson & Johnson (Invega Sustenna)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Ticagrelor  - Comprehensive patent search

Ticagrelor - Comprehensive patent search

Date Published: Sep 16 2014

Ticagrelor - Comprehensive patent search Prevention of thrombotic events in a patient with acute coronary syndromes, optionally in combination with Aspirin AstraZeneca (Brilinta, Possia, Brilique)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Mipomersen  - Comprehensive patent search

Mipomersen - Comprehensive patent search

Date Published: Sep 16 2014

Mipomersen - Comprehensive patent search Reduction of low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and non-high density lipoprotein-cholesterol in patients with homozygous familial hypercholesterolaemia, in combination with lipid-lowering drugs Genzyme (Kynamro)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Elvitegravir  - Comprehensive patent search

Elvitegravir - Comprehensive patent search

Date Published: Sep 16 2014

Elvitegravir - Comprehensive patent search Treatment of HIV-1 infection in combination with Cobicistat, Emtricitabine and Tenofovir disoproxil fumarate, or Ritonavir-boosted protease inhibitors or other antiretrovirals Gilead (Stribild); Gilead (Vitekta); Japan Tobacco (Vitekta)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Date Published: Jul 31 2014

Exceptionally Large and Innovative Pipeline

$6,995.00
Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation

Date Published: Jun 30 2014
GBI Research has released the pharma report: “Frontier Pharma: Psoriasis Identifying and Commercializing First-in-Class Innovation”, which identifies and assesses first-in-class innovation in the psoriasis development pipeline.
 
$6,995.00
Mirabegron  - Comprehensive patent search

Mirabegron - Comprehensive patent search

Date Published: Sep 16 2014

Mirabegron - Comprehensive patent search Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency Astellas (Myrbetriq, Betmiga)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$6,201.00
Tolvaptan  - Comprehensive patent search

Tolvaptan - Comprehensive patent search

Date Published: Sep 16 2014

Tolvaptan - Comprehensive patent search Treatment of hypervolemic and euvolemic hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion and congestive heart failure Otsuka Pharm (Samsca); Aspen (Samsca)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$6,200.00
Enzalutamide  - Comprehensive patent search

Enzalutamide - Comprehensive patent search

Date Published: Sep 16 2014

Enzalutamide - Comprehensive patent search Treatment of metastatic castration-resistant prostate cancer Medivation (MDV3100); Astellas Pharma (Xtandi)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$6,200.00
Antibody Report Bundle

Antibody Report Bundle

Date Published: Mar 18 2014

Market Reserach Reports, Inc is running a promotion until the end of April for a bundle of four antibody-related reports with a 50% discount on the list price (or four reports for the price of two).

To see each report's table of contents and details please visit following links:

$4,766.00
Global Nonalcoholic Steatohepatitis (NASH) Market (Pipeline analysis, drug class, clinical trials and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Global Nonalcoholic Steatohepatitis (NASH) Market (Pipeline analysis, drug class, clinical trials and Geography) - Forecast, 2013 - 2020

Date Published: Aug 1 2014
$4,515.00

Pages

Shopping cart

0 Items $0.00
Market Research Special Offers
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data